Physician profile
Christopher Cheng
NPI 1487713053
$593.80
in general payments reported to CMS, 2019-2025
9 companies · $11.26 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.03 · 2022: $151 · 2023: $379 · 2024: $28.95 · 2025: $11.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $249.46 | 2022-2023 | Inspire |
| Axsome Therapeutics, INC. | $131.55 | 2023 | Sunosi |
| Idorsia Pharmaceuticals US INC | $56.30 | 2023 | Quviviq |
| Alexion Pharmaceuticals, INC. | $42.55 | 2023 | Ultomiris |
| Biohaven Pharmaceutical Holding Company LTD. | $29.92 | 2022 | |
| Jazz Pharmaceuticals INC. | $28.95 | 2024 | |
| Sunovion Pharmaceuticals INC. | $23.03 | 2020 | |
| Argenx US, INC. | $20.78 | 2023 | Vyvgart |
| 3b Medical, INC. | $11.26 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.